VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Sartorius Stedim Biotech S.A. vs Jack Henry & Associates, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sartorius Stedim Biotech S.A.
DIM · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Sartorius Stedim Biotech S.A.'s moat claims, evidence, and risks.
View DIM analysisJack Henry & Associates, Inc.
JKHY · Nasdaq
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Jack Henry & Associates, Inc.'s moat claims, evidence, and risks.
View JKHY analysisComparison highlights
- Moat score gap: Sartorius Stedim Biotech S.A. leads (80 / 100 vs 59 / 100 for Jack Henry & Associates, Inc.).
- Segment focus: Sartorius Stedim Biotech S.A. has 2 segments (75% in Sterile single-use bioprocessing consumables); Jack Henry & Associates, Inc. has 3 segments (36.8% in Payments).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: Sartorius Stedim Biotech S.A. has 6 moat types across 3 domains; Jack Henry & Associates, Inc. has 7 across 3.
Primary market context
Sartorius Stedim Biotech S.A.
Sterile single-use bioprocessing consumables
Sterile single-use bioprocessing consumables (bags, filters, fluid management components)
Global
Biopharmaceutical manufacturers and CDMOs
Consumables supplier (single-use)
75%
Jack Henry & Associates, Inc.
Payments
Payment processing and transaction services for financial institutions (card, ACH, bill pay, faster payments, settlement support)
United States
Banks, credit unions, and their accountholders; businesses via FI clients
Processor and settlement/risk services provider
36.8%
Side-by-side metrics
Moat coverage
Shared moat types
Sartorius Stedim Biotech S.A. strengths
Jack Henry & Associates, Inc. strengths
Segment mix
Sartorius Stedim Biotech S.A. segments
Full profile >Sterile single-use bioprocessing consumables
Oligopoly
Bioprocessing equipment, systems, and software/services
Oligopoly
Jack Henry & Associates, Inc. segments
Full profile >Core
Oligopoly
Payments
Competitive
Complementary
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.